This inventor holds 72 USPTO granted patents and 23 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Vascular Growth Factors (CPC class C07K). Top assignees: Vegenics Pty Limited, Vegenics Limited, Ludwig Institute for Cancer Research Limited. Active years: 1997-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- FIN-00210 Espoo, FI (1999)
- Helsinki, SE (1999)
- University of Helsinki, FI (2006 - 2009)
- Espoo, FI (1998 - 2013)
- Helsinki, FI (1997 - 2019)
Company Filing History:
16 out of 22 
15 out of 19 
14 out of 530 
Years Active: 1997-2019
Areas of Expertise:
Title: Kari Alitalo: Innovating Solutions for Transplantation and Arteriosclerosis
Introduction:
In the realm of medical advancements, Kari Alitalo has made a significant mark with his contributions to the field. Hailing from Helsinki, Finland, Alitalo's immense expertise and innovative mindset have led to the development of numerous patents and methodologies, especially in the areas of solid organ transplant protection and the prevention of arteriosclerosis. Let's delve into his latest patents, career highlights, notable collaborations, and the impact of his work.
Latest Patents:
Kari Alitalo's latest patents demonstrate his commitment to finding effective solutions for various medical conditions associated with ischemia, reperfusion injury, and chronic transplant rejection. One such patent involves the use of antibodies or antigen-binding fragments against Angiopoietin-2 (Ang-2) to treat ischemia. These methods not only reduce inflammation and increase microvascular perfusion but also aid in protecting solid organ transplant tissue and preventing chronic tissue transplant rejection.
Another notable patent relates to the antagonization of vascular endothelial growth factor receptors and platelet-derived growth factor receptors, among others, to prevent allograft rejection or arteriosclerosis after organ transplantation. These materials and methods play a crucial role in inhibiting or ameliorating the adverse effects of transplantation and reducing the risks associated with transplant-related complications.
Career Highlights:
Throughout his career, Kari Alitalo has accumulated an impressive portfolio of 72 patents. His contributions significantly advance the field of medicine, particularly in organ transplantation and mitigating complications associated with it. The methods he developed allow for improved post-transplantation outcomes, reduced rejection rates, and enhanced patient well-being.
Collaborations:
Kari Alitalo's work has benefited from collaborations with esteemed colleagues, and two notable individuals stand out: Vladimir Joukov and Marc Gregory Achen. These collaborations have dynamically contributed to the advancement of research in transplantation and arteriosclerosis.
Conclusion:
Kari Alitalo's relentless pursuit of innovative solutions and extensive expertise within the medical field have resulted in a remarkable number of patents focused on solid organ transplant protection and preventing arteriosclerosis. His methods and techniques are vital in improving patient outcomes and reducing the complications associated with organ transplantation. As Kari Alitalo continues to push the boundaries of medical science, we can expect further groundbreaking contributions to the field of transplantation and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile